Abnormal Glycosylation in Cancer Cells and Cancer Stem Cells as a Therapeutic Target.

Quader, Sabina; Tanabe, Shihori; Cabral, Horacio

Quader, Sabina; Tanabe, Shihori; Cabral, Horacio.

Afiliação

Quader S; Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, 210-0821, Japan.
Tanabe S; Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan.
Cabral H; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan. horacio@bmw.t.u-tokyo.

Adv Exp Med Biol ; 1393: 141-156, 2022.

Article em En | MEDLINE | ID: mdl-36587306

Assuntos

Neoplasias; Humanos; Glicosilação; Neoplasias/metabolismo; Células-Tronco Neoplásicas/patologia

Palavras-chave

Cancer stem cells; Glycosylation; Phenylboronic acid; Signaling pathways

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google